HD Melphalan and SCT in Patients With IGDD or LCDD

NCT00681044 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

5

Enrollment

OTHER

Sponsor class

Stopped Poor accrual

Conditions

Multiple Myeloma

Interventions

BIOLOGICAL: filgrastim
DRUG: melphalan
PROCEDURE: Stem Cell Infusion

Sponsor

Boston Medical Center